Published Application/Species/Sample/Dilution | Reference |
---|
- western blot; human; fig 3a
| Nicolazzo C, Raimondi C, Mancini M, Caponnetto S, Gradilone A, Gandini O, et al. Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab. Sci Rep. 2016;6:31726 pubmed publisher
|
- western blot; human; fig 1
| Tsaktanis T, Kremling H, PavÅ¡iÄ M, von Stackelberg R, Mack B, Fukumori A, et al. Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM). J Biol Chem. 2015;290:24574-91 pubmed publisher
|
| Morancho B, MartÃnez Barriocanal Ã, Villanueva J, Arribas J. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Res. 2015;17:106 pubmed publisher
|
- western blot; human; fig 6
| Thieme R, Kurz S, Kolb M, Debebe T, Holtze S, Morhart M, et al. Analysis of Alpha-2 Macroglobulin from the Long-Lived and Cancer-Resistant Naked Mole-Rat and Human Plasma. PLoS ONE. 2015;10:e0130470 pubmed publisher
|
- western blot; human; fig 7
| Chiappetta G, Valentino T, Vitiello M, Pasquinelli R, Monaco M, Palma G, et al. PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration. Oncotarget. 2015;6:5310-23 pubmed
|
- western blot; human; fig 6
| Even Desrumeaux K, Nevoltris D, Lavaut M, Alim K, Borg J, Audebert S, et al. Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display. Mol Cell Proteomics. 2014;13:653-65 pubmed publisher
|
| Lee J, Jeong S, Li Z, Kim H, Kim H, Yoo M, et al. Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models. Biomater Res. 2023;27:18 pubmed publisher
|
| Zhong C, Wu J, Izpisua Belmonte J. Pig Chimeric Model with Human Pluripotent Stem Cells. Methods Mol Biol. 2019;2005:101-124 pubmed publisher
|
| Shin H, Yang W, Lee E, Han G, Cho H, Chay D, et al. Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression. PLoS ONE. 2018;13:e0205297 pubmed publisher
|
| Ai L, Kim W, Alpay M, Tang M, Pardo C, Hatakeyama S, et al. TRIM29 suppresses TWIST1 and invasive breast cancer behavior. Cancer Res. 2014;74:4875-87 pubmed publisher
|
| Martowicz A, Rainer J, Lelong J, Spizzo G, Gastl G, Untergasser G. EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth. Mol Cancer. 2013;12:56 pubmed publisher
|
| Hagman Z, Haflidadóttir B, Ceder J, Larne O, Bjartell A, Lilja H, et al. miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients. Br J Cancer. 2013;108:1668-76 pubmed publisher
|
| Sankpal N, Mayfield J, Willman M, Fleming T, Gillanders W. Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion. Breast Cancer Res. 2011;13:R124 pubmed publisher
|
| Argani P, Hicks J, De Marzo A, Albadine R, Illei P, Ladanyi M, et al. Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol. 2010;34:1295-303 pubmed publisher
|
| Cimino A, Halushka M, Illei P, Wu X, Sukumar S, Argani P. Epithelial cell adhesion molecule (EpCAM) is overexpressed in breast cancer metastases. Breast Cancer Res Treat. 2010;123:701-8 pubmed publisher
|